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Abstract
Background and Scope
Weight loss success is dependent on the ability to refrain from regaining the lost weight in
time. This feature was shown to be largely variable among individuals, and these differ-
ences, with their underlying molecular processes, are diverse and not completely eluci-
dated. Altered plasma metabolites concentration could partly explain weight loss
maintenance mechanisms. In the present work, a systems biology approach has been
applied to investigate the potential mechanisms involved in weight loss maintenance within
the Diogenes weight-loss intervention study.
Methods and Results
A genome wide association study identified SNPs associated with plasma glycine levels
within the CPS1 (Carbamoyl-Phosphate Synthase 1) gene (rs10206976, p-value = 4.709e-
11 and rs12613336, p-value = 1.368e-08). Furthermore, gene expression in the adipose tis-
sue showed that CPS1 expression levels were associated with successful weight mainte-
nance and with several SNPs within CPS1 (cis-eQTL). In order to contextualize these
results, a gene-metabolite interaction network of CPS1 and glycine has been built and ana-
lyzed, showing functional enrichment in genes involved in lipid metabolism and one carbon
pool by folate pathways.
Conclusions
CPS1 is the rate-limiting enzyme for the urea cycle, catalyzing carbamoyl phosphate from
ammonia and bicarbonate in the mitochondria. Glycine and CPS1 are connected through
the one-carbon pool by the folate pathway and the urea cycle. Furthermore, glycine could
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be linked to metabolic health and insulin sensitivity through the betaine osmolyte. These
considerations, and the results from the present study, highlight a possible role of CPS1
and related pathways in weight loss maintenance, suggesting that it might be partly geneti-
cally determined in humans.
Introduction
Obesity is a major risk factor for cardiovascular diseases, hypertension, insulin resistance and
type 2 diabetes as well as some cancers [1,2]. Multiple studies have shown that weight loss
achieved through energy restricted dietary interventions improves the metabolic dysfunctions
involved in metabolic syndrome [3–5], and prevents type 2 diabetes. However, the capacity to
lose weight and, in particular, to avoid weight regain, shows inter-individual variability that
hitherto cannot be explained only by differences in exogenous environmental exposures and
lifestyle factors [6,7]. Several studies have shown that this heterogeneity is, at least in part, due
to physiological/molecular metabolism differences [8,9]. For example, overfeeding studies have
demonstrated a threefold difference in energy efficiency, in turning calories into body mass
between individuals [10]. Still, the molecular mechanisms contributing to successful weight
loss/maintenance remain poorly understood. Obesity and weight change are complex, and, in
order to aid their comprehension, an integrated, multidisciplinary approach is necessary. Here,
we show results from combining different types of “omics” data from a large dietary interven-
tion study, with a network analysis approach, in order to elucidate the biological functions
involved in the weight maintenance capacity in humans.
Molecular phenotypes can be used as an intermediate to help in identifying relationships
between genetic variants and a more global phenotype, such as weight maintenance. For
instance, blood metabolite profile can be used to differentiate between obese and lean individu-
als [11]. For example, plasma glycine levels were negatively correlated with BMI and associated
with genetic variants within the carbamoyl-phosphate synthase 1 (CPS1) gene, which encodes
for a mitochondrial enzyme that catalyzes the synthesis of carbamoyl phosphate from ammo-
nia and bicarbonate [12,13]. These observations raise the possibility that alterations in plasma
metabolite concentrations could reflect changes of metabolic processes involved in weight
maintenance [14].
The integration of experimental data with systems biology methods could point to possible
not yet known pathways to explore [15,16]. With this aim, the utilization of metabolite-protein
and protein-protein interaction networks, built from databases, is a powerful way to investigate
metabolic pathways potentially correlated with the condition of interest [17]. Networks can
allow the consideration of nodes and pathways that would not have been explored with other
methodologies. For example, Emilsson et al. [18] constructed an extensive co-expression net-
work on the basis of the human adipose tissue data, to investigate key functional modules asso-
ciated with obesity, and found that many of the interconnected genes were also associated with
the inflammatory response and pathways linked to macrophage activation. In the present work
we built a metabolite/protein interaction network of CPS1 and glycine, in order to investigate
whether there could be a link between the pathways in which these are involved, and the com-
plex nature of weight loss and regain, in combination with genetic, metabolomic, transcrip-
tomic and anthropometric data.
The presented results are based on data from one of the worldwide largest dietary interven-
tion study, the Diet, Obesity, and Genes study (DioGenes) [19]. DioGenes is a multicenter, ran-
domized controlled dietary intervention study, involving 8 European countries, which started
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in 2005. 938 eligible adults underwent an 8-week weight-loss phase following a complete meal
replacement low calorie diet (800–1000 kcal/day total energy intake). Subjects who achieved at
least 8% weight loss (n = 773) were randomly assigned to one of five weight maintenance arms
for 26-weeks. In this paper we will refer as baseline (BL), the initial state (before the study),
post-weight loss (PWL) the time after the 8 weeks weight loss period and (PWM) the time
point after the 6 months weight maintenance phase. The DioGenes study is unique in its avail-
ability of multiple “omics” data from the different time points, including metabolomics, prote-
omics, adipose tissue RNA expression and genotype data on all participants.
Materials and Methods
DioGenes was registered in ClinicalTrials.gov (NCT00 390637). Briefly, 932 overweight and
obese adults in 8 European centers participated in a dietary program with an 8-week 800–1000
kcal/day whole meal replacement low-caloric diet (LCD; Modifast, Nutrition et Santé, France).
Subjects achieving at least 8% of initial body weight loss were randomized to a 6-month ad libi-
tum weight maintenance diet (WMD) consisting in one of four low-fat diets that differed in
glycemic index and protein content, or a control diet as described in [20]. Abdominal subcuta-
neous fat biopsies from the DioGenes protocol were obtained by needle aspiration under local
anesthesia after an overnight fast at baseline, at the end of LCD and at the end of WMD. All
clinical investigations were performed according to standard operating procedures. Analysis of
blood samples was performed at the Department of Clinical Biochemistry, Gentofte University
Hospital, Denmark. The study was performed according to the latest version of the Declaration
of Helsinki and the Current International Conference on Harmonization (ICH) guidelines. All
subjects gave verbal and written informed consent. Ethical approval was obtained from all the
regional Ethics Committees of the eight participating centers. The study protocol and informed
consent document were approved by the Medical Ethical Committees of Maastricht University
and the University of Copenhagen.
Measurement of targeted blood metabolites
After 12-hour overnight fast, venipuncture was performed in the morning. Fasting blood sam-
ples were obtained at each of the 3 CIDs for the analysis of blood metabolites, as also outlined
in [20]. NMR measurements were performed by mixing serum samples (100 microliter) with
100 microliter buffer, transferring this to 3 mm NMR tubes and subsequent measurements on
a Bruker Avance III NMR spectrometer with cryoprobe. The temperature for the measure-
ments was 37°C and metabolites were determined from 1H J-RES data [21]. The spectra
obtained were automatically aligned, phase corrected, base line corrected and integrated. Using
the described approach, 36 metabolites could automatically be quantified from the NMR data-
sets. Eighteen of these metabolites (glucose, acetate, n-acetyl, acetoacetate, proline, glycine, ala-
nine, leucine, isoleucine, valine, tyrosine, creatinine, creatine, lactate, 3-OH-butyrate,
hydroxyisobutyrate, oxo-isovaleric acid, urea) passed QC and were included in the GWAS
study.
Genotype data
Genomic DNA was extracted from the buffy coats with a salting out method. Genomic and
amplified DNA samples were quality-checked, quantified and normalized to approximately
100 ng/ml and 2.0 mg before genotyping. High throughput SNP genotyping was carried out
using the Illumina iScan Genotyping System (Illumina, San Diego, CA, USA). 748 individuals
were genotyped using the Illumina 660W-Quad SNP chip. SNP genotyping was done in accor-
dance with manufacturer’s protocols. The Integrated mapping information is based on NCBI’s
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build 37. Pre-processing of the genotype data was performed with plink (v1.07), which is a free,
open-source whole genome association analysis toolset, developed by Shaun Purcell at the Cen-
ter for Human Genetic Research, Massachusetts General Hospital and Broad Institute of Har-
vard and MIT [22,23]. The parameters used were mind = 0.01 and geno = 0.01. Furthermore
SNPs with MAF< 0.05 and SNPs not in hardy Weinberg equilibrium (p< 10–4) were
excluded leading to a set of 456,382 informative SNPs. Pair-wise linkage disequilibrium [24]
was calculated with the LDlink web-based application using 1000 Genome phase 3 data (for
the CEU population).
Genome-wide Association Statistics
For association analyses plink software was used. A principal component analysis was per-
formed based on all SNPs after quality control. Principal components were used to control for
genetic heterogeneity during association analyses. The number of subjects for which both
genotype and metabolite data were available are 641. Linear regression was performed for each
SNP for all of the 18 metabolites (NMR) that passed QC considering their level as quantitative
traits with gender, age, center and ten first principal components form previous PCA as covari-
ates. This model examines whether each additional allele could alter the trait by equal amounts
across the three genotypes. The 5.0e-8 threshold was used to evaluate the significance of each
association.
Networks and gene enrichment
Networks were built from the central nodes glycine and CPS1, respectively. Metabolite—gene
interactions (glycine targets) were retrieved from Drug Bank 4.2 [25], while protein—protein
interactions were retrieved from String 10 [26]. String interactions selection was restricted to
the knowledge evidence type, which represents interactions gathered from curated databases.
String interactions have a confidence score, which was restricted to above or equal to 0.7, as
interactions above this threshold are considered to be in the high confidence range [27]. The
networks were built up to 2 neighbors from the central nodes, in order to include a sufficient
number of connections to investigate the possible biological pathways relevant to the process
under investigation. Networks were built in R library igraph [28], while Cytoscape 3.0 was used
for graphical representation. The David online tool [29,30] was used to perform gene pathway
enrichment analysis (using KEGG pathways [31]). False discovery rate (FDR) adjusted p-value
with a threshold of 0.05 was selected (this corresponded to a false discovery rate of 5%).
Gene expression
RNA extraction, storage and QC was performed as described in [32]. RNA-seq data from adi-
pose tissues was generated using a pipeline for parallel job submission which consists of RNAS-
tar, version 2.2.0.c [33], with standard parameters, for the alignment process, of samtools,
version 0.1.18 [34], for sam/bam file manipulation, and bedtools multicov, version 2.16.2 [35],
for computation of transcripts coverage. The genome reference used for mapping was NCBI
build 37 (GRCh37).
eQTL mapping
eQTL analysis in adipose tissue was performed on a subset of 450 individuals from the Dioge-
nes cohort where both the RNA-seq data at time BL and genotype data were available. Pre-pro-
cessing of the genotype data was performed with plink [22,23] using the same parameters has
for the GWAS, leading to a total of 482826 SNPs. The eQTL analysis was performed with the R
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package MatrixEQTL [36] using a linear model with the following covariates: sex, age and sam-
pling center and 10 first PCs of population stratification. A threshold of adjusted p-value
(FDR)< 0.05 was set.
Statistical methods
The statistical software R 3.0.3 [37] was used for the statistical analysis. A p-value of 0.05 was
defined as significance threshold except where otherwise mentioned. The function lm from the
stats package in R was used for analyzing the relationship between BMI fold change (between
post weight maintenance and post weight loss, computed as (BMI PWM-BMI PWL)/BMI
PWL) and gene expression. The same functions were applied to investigate the difference in
gene expression between weight maintainers (WMs), defined as subjects which BMI did not
change more than 4% during the weight maintenance phase (n = 55) [38], and weight regainers
(WRs), whose weight increased by more than 4% (n = 136). Outliers were removed according
to the “outlier labeling rule” [39] (k = 1.5), using one iteration, when comparing gene expres-
sion in WMs andWRs. The finally compared groups for CPS1 gene expression were of 132
and 53 for WMs and WRs, respectively. S2 Fig shows CPS1 gene expression box plots before
and after outliers’ removal. Regressions were corrected for age and sex.
Results
GWAS of glycine level
Of the eighteen metabolites analyzed only two showed genome-wide significant associations
with SNPs. We identified an association between rs2238732 in the PRODH gene and proline
levels. The association of markers in the PRODH gene with proline levels has already been
reported by Shin SY et al. [40]. However, neither proline levels nor any of the SNPs in PRODH
associated with measure of weight loss/weight maintenance and were not pursued further. We
also confirmed the genome-wide association between polymorphisms upstream of CPS1 gene
and blood-derived glycine level in 641 European individuals from the population based DioGe-
nes study [19].
These analyses have identified two loci at genome-wide significance (P< 5.0e-8) in CPS1:
rs10206976 (chr 2:210749914 p-value = 4.709e-11, with allelic odds ratio (OR) = 1.23) and
rs12613336 (chr 2:210704675 p-value = 1.368e-08, OR = 1.19) associated with the glycine level
in the blood samples (Fig 1). The variant rs1047891 (chr2:210675783), causing the missense
mutation Thr1412Asn, was identified as the most probable causal variant using a fine mapping
approach [13]. This variant was not in the SNP array used in our study, but is in LD with the
SNPs rs10206976 (r = 0.51 D-prime = 1) and rs12613336 (r = 0.5128, D-prime = 0.923).
CPS1 eQTL analysis
The gene expression profiling from RNA-seq in adipose tissues at baseline for 450 individuals
in the DioGenes cohorts were used to find genetic associations with the CPS1 transcription lev-
els. Genetic mapping of the expression of CPS1 revealed significant eQTLs (adjusted p-value
(FDR)< 0.05). Among those, 17 SNPs were defined as cis-eQTLs since they were located
within 100 kbp from the transcription start site of the gene that was measured. Fig 2 shows the
association between CPS1 transcription level and the SNP rs3856348 showing the strongest
association (p-value = 2.477e-24). Using the LDlink a web-based application [24], one of these
SNPs was found to be in linkage disequilibrium (D-prime> 0.6, R-squared = 0.101) with the
glycine associated GWAS SNP rs1047891 (see Table 1).
CPS1 and the Urea Cycle in Weight Maintenance
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Glycine and CPS1 networks
In order to explore the glycine and CPS1 connected pathways and to better understand the link
between CPS1 and glycine at the molecular level, a database search was performed to identify
protein–protein interactions for CPS1, and protein–metabolite interactions for glycine. Find-
ings from these searches were converted into networks, where nodes represent proteins (or gly-
cine), and edges represent protein–protein (or glycine-protein) interactions. The glycine-
centered network resulted in 383 nodes and the CPS1—centered network in 77 nodes. The
merged glycine and CPS1 network resulted in 427 nodes (33 shared nodes), shown in Fig 3.
Gene functional enrichment for the 426 genes in the CPS1—glycine network for KEGG path-
ways [31,41] showed enrichment for 22 terms (adjusted p-value (FDR)< 0.05), reported in S1
Fig. The top pathway for significance is the Neuroactive ligand-receptor interaction (adjusted
Fig 1. Manhattan plot of Glycine. (a) Genome-wide association of glycine and (b) zoom on chromosome 2. The two green dots represent the SNPs
significantly associated with glycine levels: rs10206976 (chr 2:210749914) and rs12613336 (chr 2:210704675), in theCPS1 gene. Significativity (p—
value = 5.0e-8) and suggestive (p—value = 1.0e-5) thresholds are provided as red and blue lines respectively.
doi:10.1371/journal.pone.0150495.g001
CPS1 and the Urea Cycle in Weight Maintenance
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p-value (FDR) 3.48 e-36). Interestingly, the One carbon pool by folate pathway is represented
at the seventh place, with a p-value of 1.45 e-10.
Weight maintenance and gene expression
In order to investigate whether there was a relation between weight maintenance and CPS1
gene expression, the latter was investigated in successful WMs andWRs individuals. WMs
were defined as subjects whose BMI did not vary more than 4% during the weight maintenance
phase, while WRs were defined as subjects whose weight increased by more than 4% [38].
CPS1 gene expression at the beginning of the weight maintenance phase was significantly dif-
ferent between the two groups (Fig 4, p-value = 0.04, correcting for age and sex).
The same analysis was performed for all the genes in the CPS1-Glycine network, and the
expression value of 45 genes (adjusted p-value (FDR)< 0.1) at the beginning of the weight
Fig 2. CPS1 and rs3856348. Correlation between genotypes at rs3856348, andCPS1 transcription level.
doi:10.1371/journal.pone.0150495.g002
CPS1 and the Urea Cycle in Weight Maintenance
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maintenance phase was significantly different between WMs and WRs. The significant genes
and corresponding p-values are reported in Table 2.
Gene expression at the end of the weight maintenance phase of 426 genes within the CPS1-
Glycine network was analyzed with respect to BMI variation between pre and post weight loss.
In a multiple linear regression, the variation in expression of 10 genes was significantly
(adjusted p-value (FDR)< 0.1) correlated with BMI variation during weight maintenance
(Table 3).
Discussion
The results show that genetic variants in CPS1, the rate-limiting enzyme of the urea cycle, are
strongly associated with plasma glycine levels, and that differences in the expression of CPS1
suggest a potential causal association with an individual’s capacity to maintain weight after
weight loss. This shows the relevance of studying intermediate phenotypes, such as metabolites
level, within GWAS results.
In order to insert the results into a broader biological context, building networks helped to
identify pathways of interest that would not have been conventionally studied. Glycine is an
important metabolite for some key pathways, like the urea cycle, the folate cycle and the one-
carbon metabolism. Specifically, glycine provides a precursor pool for betaine, which is an
important osmolyte and methyl donor. Betaine has been associated with metabolic, liver and
heart health in humans [42]. A high betaine intake has been shown to correlate with higher
insulin sensitivity and lower BMI in mice [42,43].
So how may genetic variants and the differences in CPS1 gene expression contribute to dif-
ferences in the capacity to maintain weight? One possible model is that individuals who regain
weight have a preference to use amino acids and proteins as energy source. They produce more
NH4+, which induces CPS1 expression and leads to more urea. The individuals, who have less
Table 1. Pair-wise linkage disequilibrium.
SNP GWAS cis-eQTL snp MAF of GWAS SNP MAF of cis-eQTL SNP Distance RSquared DPrime
rs1047891 rs7607205 0.2885 0.261 51404 0.101 0.6092
rs1047891 rs2287598 0.2885 0.2951 17344 0.0271 0.5789
rs1047891 rs6725770 0.2885 0.1611 186309 0.032 0.5263
rs1047891 rs6714124 0.2885 0.4732 104442 0.0424 0.3511
rs1047891 rs2371001 0.2885 0.4617 72959 0.036 0.3204
rs1047891 rs2887913 0.2885 0.4141 120300 0.0107 0.2172
rs1047891 rs2012564 0.2885 0.4814 136782 0.0075 0.1798
rs1047891 rs981024 0.2885 0.4105 143827 0.0075 0.1798
rs1047891 rs7573258 0.2885 0.3756 102111 0.0089 0.1398
rs1047891 rs4672587 0.2885 0.3371 3661 0.0108 0.1316
rs1047891 rs2371000 0.2885 0.3644 74727 0.0062 0.1152
rs1047891 rs3856348 0.2885 0.4645 194511 0.0035 0.1023
rs1047891 rs10932334 0.2885 0.4808 199158 0.0027 0.0921
rs1047891 rs3856341 0.2885 0.1062 205860 0.0018 0.0638
rs1047891 rs3732055 0.2885 0.4748 205799 0.0003 0.0289
rs1047891 rs3770685 0.2885 0.4549 201675 0.0002 0.0153
rs1047891 rs2287603 0.2885 0.2047 113533 0 0.0053
Pairwise linkage disequilibrium between the SNP associated to glycine levels and SNPs associated to CPS1 transcription. The minor allele frequency
(MAF) of the GWAS SNP and the cis-eQTL SNPs were taken from dbSNP.
doi:10.1371/journal.pone.0150495.t001
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amino acid and protein metabolism, use fat as energy source. They therefore produce less NH4
+ and CPS1 is less induced. As a result of higher fat oxidation these individuals may be better at
maintaining body weight. This is consistent with the observation that urea levels are higher in
weight regainers. In general it has become clear that obese individuals are less flexible in the
change from carbohydrate to fat oxidation leading to lower fat oxidation and insulin resistance
[44]. The genetic variants influencing CPS1 gene expression would accentuate this effect and
would also explain the observed association between the SNPs and glycine levels in the blood.
Individuals with a genotype leading to higher CPS1 expression have less glycine (at the same
input level of NH4+) and the individuals who express less CPS1 protein have more glycine in
the blood. Glycine is a major biochemical mechanism to eliminate ammonia. Glycine conjugat-
ing with benzoic acid leads to hippuric acid, which is abundantly found in urine samples.
Variations in CPS1 quantity and thus the glycine pool may also influence one-carbon
metabolism and the bioavailability of betaine. It is noteworthy that the one-carbon metabolism,
apart from providing one-carbon bodies for many building blocks in the cell, has been also
shown to be linked more directly to mitochondrial function [45] and thus, to energy
Fig 3. CPS1 –Glycine network.Networks for CPS1 and Glycine (77 and 383 nodes, respectively) were built from publicly available databases and
subsequently merged. Purple nodes belong to the CPS1 network; green nodes belong to the Glycine network; orange nodes are shared between the two
networks (33). The bigger nodes represent CPS1 and Glycine. Nodes with bigger labels represent the genes in the One carbon pool by folate KEGG pathway
underlined from the gene enrichment analysis.
doi:10.1371/journal.pone.0150495.g003
CPS1 and the Urea Cycle in Weight Maintenance
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Fig 4. CPS1 gene expression and weight maintenance. Box plots for CPS1 gene expression at PWL, for
weight maintainers (WMs) and weight maintenance resistors (WRs), defined as ΔBMI < 4% and ΔBMI > = 4%
increase (p-value = 0.04, corrected for age and sex).
doi:10.1371/journal.pone.0150495.g004
CPS1 and the Urea Cycle in Weight Maintenance
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Table 2. Gene expression and weight maintenance.
n Gene symbol p-value adjusted p-value (FDR)
1 POMC 7.66E-06 0.00121
2 HRAS 8.87E-06 0.00121
3 GPX1 7.14E-06 0.00121
4 CREBBP 1.50E-05 0.00154
5 TBL1X 3.05E-05 0.00209
6 NCOA1 2.97E-05 0.00209
7 GRIN3A 5.10E-05 0.003
8 RASGRF2 9.73E-05 0.005
9 TAF10 1.34E-04 0.00552
10 NCOA2 1.26E-04 0.00552
11 NF1 1.66E-04 0.00621
12 MTR 2.08E-04 0.00712
13 FYN 2.84E-04 0.00898
14 MED1 5.62E-04 0.0165
15 CNIH2 6.25E-04 0.0168
16 MDH2 6.97E-04 0.0168
17 SPTLC3 6.52E-04 0.0168
18 NCOA6 8.10E-04 0.0178
19 LPAR3 8.22E-04 0.0178
20 GSS 1.36E-03 0.028
21 GPX4 1.52E-03 0.0297
22 GRHPR 1.79E-03 0.0335
23 MGST3 1.87E-03 0.0335
24 SPTLC2 3.35E-03 0.0453
25 ACY3 3.42E-03 0.0453
26 PPARA 3.39E-03 0.0453
27 ADCY9 3.46E-03 0.0453
28 SDSL 2.90E-03 0.0453
29 HCAR1 2.77E-03 0.0453
30 CCL28 3.30E-03 0.0453
31 ALDH7A1 3.53E-03 0.0453
32 CHD9 3.46E-03 0.0453
33 TAS2R41 3.78E-03 0.0471
34 GSTK1 4.04E-03 0.0489
35 GSTP1 4.39E-03 0.0515
36 CHRM4 4.62E-03 0.0527
37 BAAT 5.40E-03 0.06
38 GAL 6.65E-03 0.0643
39 PPP1CA 6.72E-03 0.0643
40 AKAP9 6.44E-03 0.0643
41 GSTO1 6.45E-03 0.0643
42 MTHFD2L 6.68E-03 0.0643
43 GFPT1 6.11E-03 0.0643
44 RUVBL2 7.46E-03 0.0697
45 GSTM3 1.07E-02 0.0973
Genes within the CPS1 glycine network for which expression levels at PWL is signiﬁcantly different
between WMs and WRs, after correction for age and sex (adjusted p-value < 0.1).
doi:10.1371/journal.pone.0150495.t002
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homeostasis. It might therefore be that the difference in the expression of CPS1 protein,
observed here ultimately impacts energy homeostasis, thereby contributing to the difference in
energy efficiency and the capacity to maintain weight after weight loss. To our knowledge this
is the first time that such a possible connection has been shown. Our results put a focus on fur-
ther studies of the relationship between the urea cycle, folate cycle and one-carbon metabolism,
on one hand, and energy metabolism on the other. It also provides further evidence that weight
maintenance is partly genetically determined in humans [9,46].
The highlighted connections between CPS1, glycine and weight maintenance, are further
supported by some of the genes in the CPS1—glycine network that are correlated with weight
maintenance and BMI variation. It is worth of notice as, within the 45 genes which expression
differed between weight maintainers and weight regainers (Table 2), some are involved in path-
ways that could be relevant to weight maintenance. For instance, several genes are involved in
fatty acids and lipids metabolism (PPARA [47–49], ALDH7A1 [50,51], BAAT [52], PPP1CA
[53] and SPTLC2 [54]). Two genes have a role within the one carbon pool by folate pathway,
MTR [55] andMTHFD2L [56]. Furthermore, the following genes are involved in diabetes and
insulin signaling:MDH2 [57], PPP1CA [58] and HRAS [59]. Also, within the 10 genes which
expression significantly correlated with BMI fold change during the weight maintenance phase
(Table 3), GNG2 [60] is involved in diabetes pathways, while ALAS1 has been shown to be
induced in diabetes in mice [30,61].
One main limitation of the present study concerns the need for further experimental verifi-
cation of the proposed biological meaning of the results. Although different analytical methods
have been applied prior to draw the reported conclusions, deeper empirical investigation
should be conducted, especially regarding the possible role of the highlighted genes, as well as
the unresolved mechanistic links between SNPs and CPS1 expression and CPS1 expression
and Glycine.
The use of biological networks from a priori knowledge, i.e. from databases, is useful for
data integration and can help biological interpretation of the system by combining comple-
mentary viewpoints, each one addressing different aspects of the system. Also, merging a net-
work analysis with independent experimental data can increase data confidence and help
interpreting the link with the investigated phenotype, i.e. weight loss maintenance in this case.
This is important especially when studying high-throughput data, which can be affected by
noise and incompleteness [62].
Table 3. Gene expression and BMI.
n Gene symbol p-value adjusted p-value (FDR)
1 ANXA1 0.0007 0.0595
2 APLN 0.0006 0.0595
3 GLUL 0.0004 0.0595
4 ALAS1 0.0003 0.0595
5 GNG2 0.0007 0.0595
6 GSR 0.0017 0.0902
7 C3AR1 0.0016 0.0902
8 CBS 0.0019 0.0902
9 GARS 0.0019 0.0902
10 P2RY14 0.0022 0.0913
Genes within the CPS1 glycine network which expression at PWM correlates with BMI fold change during
the weight maintenance phase (adjusted p-value < 0.1, correcting for age and sex).
doi:10.1371/journal.pone.0150495.t003
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Supporting Information
S1 Fig. CPS1 glycine network KEGG pathways gene enrichment. Gene enrichment per-
formed with David for KEGG pathways. The dendrogram represents the distance within GO
terms relatively to the number shared genes. The number of genes in each term is represented
in the bar chart while the color of the bars represents the % of pathway coverage (i.e. the ratio
of genes in the term in the network over the total number of genes in the term). The p-value
for each term’s enrichment is reported in the plot (adjusted p-value (FDR)< 0.05).
(TIF)
S2 Fig. CPS1 gene expression and weight maintenance before (A) and after (B) outliers
removal. Box plots for CPS1 gene expression at PWL, for weight maintainers (WMs) and
weight maintenance resistors (WRs), defined as ΔBMI< 4% and ΔBMI> = 4% increase. A)
WMs = 137, WRs = 55, p-value = 0.23. B) WMs = 132, WRs = 53, p-value = 0.04. Both regres-
sions were corrected for age and sex.
(TIF)
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